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ABSTRACT
Imaging plays a vital role in the evaluation of adrenal pathology. The
most widely used modalities are computed tomography and magnetic
resonance imaging. Alone or in conjunction with appropriate clinical
and biochemical data, imaging can provide specific diagnoses that
preclude the need for tissue sampling. This article reviews imaging fea-
tures of normal and diseased adrenals, from both benign and malig-
nant causes. (Arq Bras Endocrinol Metab 2004;48/5:592-611)
Keywords: Adrenal glands; Imaging; Computed tomography; Magnet-
ic resonance imaging
RESUMO
Procedimentos de Imagem na Patologia Adrenal.
Procedimentos de imagem têm um papel vital na avaliação da
patologia adrenal. As modalidades mais amplamente empregadas
são a tomografia computadorizada e a imagem por ressonância
magnética. Isoladas ou em combinação com dados clínicos e bio-
químicos apropriados, a imagem pode prover diagnósticos específi-
cos que dispensam a necessidade de amostras de tecido por biopsia.
Este artigo revisa os achados de imagem da adrenal normal e
patológica, incluindo tanto causas benignas como malignas. ( A r q
Bras Endocrinol Metab 2004;48/5:592-611)
Descritores: Glândulas adrenais; Imagem; Tomografia computadoriza-
da; Ressonância magnética
INTRODUCTION AND IMAGING TECHNIQUE
THE ADRENAL GLANDS CAN BE imaged through ultrasound, computedtomography or magnetic resonance imaging.
Sonography (US) of the adrenal glands is not performed routinely,
either because of the deep and often times inaccessible location of the
gland or because of the lack of specific imaging patterns, leading to non-
diagnostic studies. Adrenal pathology is therefore usually an incidental
finding in an US study performed for other reasons, and patients are
referred for further evaluation.
Computed Tomography (CT) is the primary diagnostic imaging
method for evaluation of adrenal disorders. When optimal CT scan-
ning technique is used, the normal or pathologic adrenal glands can be
well visualized in virtually 100% of patients (1). Large and small mass-
es and hyperplasia can be readily detected when present. With modern
CT scanners, imaging of the adrenals can be achieved even in the most
emaciated patients, and in patients who are unable to suspend respira-
t i o n .
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The adrenals can be well imaged with axial
slices. Most large adrenal masses can be detected with
rapid scanning with 5mm contiguous slice technique.
However, thinner slices (2.5 – 3mm, contiguous)
should be made if small lesions are suspected or if ini-
tial screening is negative in a patient strongly suspect-
ed of having adrenal disease (figure 1). Oral contrast
should be used routinely as it helps delineate the gas-
trointestinal structures of the upper abdomen, and it
helps avoid mistaking a bowel structure for an adrenal
mass. The imaging protocol must be tailored to the
clinical indication. The conditions that require differ-
ent techniques will be discussed later. For most
patients, the following technique for a helical CT study
is appropriate: 2.5 – 3mm slice thickness, with 1.5 –
3mm reconstruction interval through the adrenal
region, following oral contrast, performed before and
after intravenous injection 100 – 150ml low osmolar
iodinated contrast medium. Imaging delays after con-
trast injection are routine “portal venous phase” (60 –
90 seconds) and “delayed-phase” (15 minutes), when
appropriate. With a 4 multidetector-row CT scanner,
using HS mode (pitch 1.5 or “6”) with 1.25mm
detectors, 2.5mm slice thickness with table speed
7.5mm/rotation (1.5 pitch x 1.25mm detector x 4
row). Alternatively, in HQ mode (pitch 0.75 or “3”),
2.5mm detectors, slice thickness of 2.5mm with table
speed 7.5mm/rotation (0.75 pitch x 2.5mm detector
x 4 row). Reformatted images (in sagital or coronal
plane) can sometimes be useful in determining
whether a mass arises from the adrenal, liver or kidney.
Great strides have been made in magnetic reso-
nance imaging (MRI) of the abdomen; and with cur-
rent techniques, the adrenals also can be delineated in
nearly all patients with MRI (2-4). Patients who are
claustrophobic, are unstable or erratic breathers,
exceed the size limits, or have pacemakers cannot be
evaluated with MRI. State-of-the-art MRI scanners
now produce thin sections (3 to 5mm) with good spa-
tial resolution and signal-to-noise ratio. The use of res-
piratory compensation techniques, or rapid imaging
sequences that can be performed during suspended
respiration, produces images without significant
motion artifacts. Fat suppression makes normal adren-
als very conspicuous on T2-weighted images: they are
bright, in contrast to surrounding retroperitoneal fat.
Intravenous contrast agents now available for MRI
provide information about enhancement patterns of
masses that is similar to that obtained with contrast-
enhanced CT. Techniques sensitive to the presence of
lipid (such as in/out-phase and fat suppression) are
most useful in differentiating between subacute hem-
orrhage and fat-containing adrenal masses, both of
which can appear as high signal lesions on T1-weight-
ed spin echo images.
An MRI evaluation of the adrenals usually con-
sists of: T1 gradient refocused echo (GRE) weighted
sequences in and out of phase in the axial and coronal
planes, 3 to 5mm slice thickness; a T2-weighted TSE
sequence with fat saturation in the axial plane, 3 to
5mm slice thickness; and a T2-weighted HASTE
sequence in the coronal plane, slice thickness of 5mm.
The use of intravenous contrast agents should be lim-
ited to those cases where there rests a doubt, being, in
those cases, used to differentiate solid lesions from
hemorrhages, and in cases of pheochromocytoma. The
use of such contrast media is not yet established in the
diagnosis of adenomas.
Despite the many improvements in MRI that
allow more rapid data acquisition, an MRI examina-
tion of the adrenals is still a relatively lengthy proce-
dure compared to CT. Therefore, it is most useful as
an alternative to CT in patients who cannot tolerate
intravenous iodinated contrast, in cases of suspected
pheochromocytoma and to confirm a diagnosis of
hemorrhage.
Figure 1. Use of thinner collimation. A: CT with 7mm contiguous sections demonstrates an equivocal right adrenal nodule.
B: Repeat with contiguous 3mm sections clearly shows a small nodule (arrow).
Imaging Procedures in Adrenal Pathology
Goldman et al.
594 Arq Bras Endocrinol Metab vol 48 nº 5 Outubro 2004
NORMAL ANATOMY
The adrenal glands are paired retroperitoneal organs
that lie in a suprarenal location and are enclosed with-
in the perinephric fascia. The right adrenal is usually
seen directly superior to the upper pole of the right
kidney with its most caudal portion just anterior to the
upper pole. The right adrenal is directly posterior to
the inferior vena cava and insinuates between the right
lobe of the liver and the right crus of the diaphragm.
The left adrenal may be seen at the same level as the
right, but it often is slightly more caudal. It is antero-
medial to the upper pole of the left kidney and is usu-
ally seen on CT in the same slice as the left kidney. The
left adrenal lies lateral to the aorta and the left
diaphragmatic crus, and superior to the left renal vein.
A portion of the pancreas or the splenic vessels may be
immediately anterior to the left adrenal. When per-
forming a dedicated (thin section) CT of the adrenals,
it is important to obtain a sufficient number of images,
because the adrenals each extend about 2 to 4cm in
craniocaudal direction, and because masses may pro-
trude superiorly or inferiorly.
The adrenal glands have medial and lateral
limbs extending posteriorly from central ridges.
Inverted V, Y, L, and other configurations may be
seen. On precontrast CT, the adrenals have a soft-tis-
sue density similar to that of the liver. If very early
post-contrast scans are obtained, there is considerable
enhancement, which fades quickly to moderate
enhancement – slightly less than that of liver. The
adrenal cortex and medulla cannot be reliably distin-
guished by either CT or MRI. On T1-weighted MRI
images, the adrenals have intermediate signal intensity,
similar to that of the liver, somewhat greater than the
diaphragmatic crus but much less than the surround-
ing fat (5). On standard T2-weighted images, the
adrenals are hypointense to fat and isointense to liver,
but they are hyperintense to the crus. There is less dif-
ference between adrenal and fat signal intensities on
T2-weighted images, and significant chemical shift
artifact may obscure details of the normal adrenals. On
fat-suppressed T2-weighted images, however, the nor-
mal adrenals appear somewhat brighter than liver, and
are much brighter than the suppressed fat. Thus, nor-
mal adrenals and small masses are best seen on T1-
weighted or fat-suppressed T2-weighted images.
There is considerable variability in the lengths
of the limbs. The surface of the normal adrenal glands
should be quite smooth, without protruding nodules,
and the limbs should have uniform thickness.
Although no strict measurements have been standard-
ized, any area thicker than 10mm is abnormal. A use-
ful rough estimate of normal size is that the thickness
of the gland’s limbs should not exceed the thickness of
the ipsilateral diaphragmatic crus, at the same level. It
must be recognized that in the face of stress (as may be
seen in severely ill patients), the adrenals may become
enlarged in response to physiologically high circulating
adrenocorticotropic hormone (ACTH) levels.
PSEUDOTUMORS
A variety of normal structures may simulate an adren-
al mass if meticulous technique is not used. The rou-
tine use of oral contrast and rapid scanning after bolus
intravenous contrast will usually allow these pseudotu-
mors to be distinguished from true adrenal masses.
Pseudotumors are less common on the right, because
there are fewer adjacent organs. Rarely, the duode-
num, stomach or colon may produce a mass-like
appearance (figure 2a). One should be careful when
interpreting images of previously splenectomized
patients, some of which develop splenosis and the
small splenic tissue nodules may mimic tumors when
located near to the adrenal space (figure 2b). Other
potential mimickers of adrenal masses on the left are
the pancreatic tail, tortuous vessels and small bowel.
PATHOLOGY
A variety of pathologic processes can affect the adrenal
glands. Some cause endocrine disorders (functional dis-
eases), either hyperfunction or adrenal insufficiency,
and some do not produce biochemical abnormalities.
Although both CT and MRI provide accurate depic-
tion of the adrenal morphology, both functional and
nonfunctional disorders may produce similar appear-
ances, so correlation of imaging findings with the
endocrine status is usually necessary for diagnosis. In
patients with biochemical evidence of adrenal hyper-
function, a CT examination is valuable because of its
ability to differentiate between a focal mass, hyperplas-
tic glands, and normal adrenals. A pathologic diagnosis
can usually be made based on the imaging appearance
of an adrenal mass and the clinical history, even when
there is no adrenal dysfunction. The accuracy of CT for
diagnosis of adrenal masses has been reported as being
better than 90% (1). With proper technique, masses
smaller than 5mm can be detected. A normal appear-
ance of the adrenal effectively excludes the presence of
an adrenal tumor. Because many small adrenal masses
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are isodense with adrenal tissue, they are detected as
focal bulges on the otherwise smooth adrenal surface.
Focal enlargement is a more important finding than
any measurement. Inability to visualize a normal adre-
nal is suggestive of adrenal origin, but extra-adrenal
malignant masses can engulf or invade the adrenal.
Large hepatic, renal, or retroperitoneal tumors may
simulate an adrenal mass. In these cases, demonstration
of a normal adrenal gland essentially excludes the pos-
sibility that the mass is adrenal in origin. Conversely,
the presence of adrenal hyperfunction confirms an
adrenal origin. The pattern of displacement of organs
likewise may be helpful in determining the center of
origin, because most tumors grow centrifugally. Right
adrenal masses typically displace the kidney inferiorly,
and the inferior vena cava anteriorly, whereas hepatic
masses rarely displace the vena cava anteriorly.
Adrenal hyperplasia may result in diffuse thick-
ening of the adrenal glands, but retention of the nor-
mal shape (figure 3). This enlargement is usually
smooth, but there may be nodularity. However, bilat-
eral enlargement, whether smooth or nodular, is
indicative of hyperplasia. A significant number of
patients with clinical and biochemical evidence of
hyperplasia will have normal adrenals with CT. In part,
this is because there may be significant hyperfunction
of the adrenal cortex before enough thickening has
occurred to be recognizable. Thus, a normal appear-
ance of the adrenals does not exclude hyperplasia.
Adrenal hyperplasia can be diagnosed when there are
bilateral nodules or when there is nodularity associat-
ed with bilateral adrenal thickening. With primary
functioning adrenal tumors, the ipsilateral remaining
adrenal tissue and contralateral adrenal gland should
be normal or atrophic. However, it is not always pos-
sible to distinguish an adenoma from a solitary hyper-
plastic nodule by CT.
On MRI, hyperplastic adrenals can be seen to
be enlarged, but the signal intensity of the tissue is
similar to that of normal adrenal gland. On occasion,
the adrenals are found to be enlarged in patients with
no evidence of adrenal dysfunction. These findings are
not clinically significant. A number of conditions have
been associated with such nonspecific hyperplasia,
including acromegaly (100%), hyperthyroidism (40%),
aortic aneurysm and dissection (55%), hypertension
with arteriosclerosis (16%), diabetes mellitus (3%), and
a variety of malignancies (6,7). In some cases, this
adrenal enlargement is a response to physiologic stress.
On imaging, the appearance is indistinguishable from
hyperplasia producing adrenal hyperfunction.
CUSHING’S SYNDROME
Cushing’s syndrome results from excess production of
cortisol by the adrenal cortex. In about 85% of cases,
this is a result of excess ACTH production (an ACTH-
dependent disorder) from a pituitary adenoma or
hyperplasia (80%), or from an ectopic source (8).
About 15% of cases of Cushing’s syndrome are ACTH
independent, usually due to a cortical adenoma or
adrenal carcinoma, rarely secondary to primary nodu-
lar hyperplasia (8,9). Adrenal CT is performed in
patients with Cushing’s syndrome to distinguish
ACTH-dependent (hyperplasia) from ACTH-inde-
pendent (focal mass) disorders, and to determine the
location of the focal mass in the latter. In patients with
Figure 2. Adrenal pseudotumor. A: An apparent mass is seen in the region of the left adrenal (arrow) on this CT was a gas-
tric fundus. B: Splenectomized patient suspected with hyperaldosteronism. One should note the nodules due to splenosis
occupying the splenic and left adrenal spaces (arrows).
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an adenoma or a carcinoma, the remaining ipsilateral
and the contralateral adrenals are normal or atrophic.
Surgical removal of an adenoma (or of a resectable car-
cinoma) is curative. Biochemical testing can be
extremely useful.
Computed tomography is virtually 100% accu-
rate for detection of adrenal adenomas resulting in
hypercortisolism. These adenomas are almost always
over 2cm at the time of presentation, are usually in the
range 2 to 5cm (10), and are readily seen on CT, espe-
cially because these patients have abundant retroperi-
toneal fat. The masses are smooth, round or oval, and
relatively homogeneous, with little enhancement after
intravenous contrast and rapid washout at 15 minutes,
in excess of 60% from baseline attenuation (11). Most
often they have a soft-tissue-attenuation value, but
they may have near water attenuation because of rela-
tively high lipid content. Calcification can be found in
adenomas, although it is rare (12) (figure 4).
The contralateral adrenal is commonly visibly
thinner than normal, indicating atrophy from ACTH
suppression (figure 5). With these findings, and in the
proper clinical setting, no further investigation is need-
ed. It should be noted that no CT characteristic has
been reported that distinguishes whether an adenoma
produces excess cortisol or aldosterone, or whether it
is not hyperfunctioning.
Magnetic resonance imaging is equally accurate
in patients with cortisol producing adenomas, because
of their size (9). Typically, the signal intensity of the ade-
nomas is similar to that of liver on T1-weighted images,
and similar or only slightly greater on T2-weighted
images (3) (figure 6). The presence of intracellular lipid
can be documented by opposed-phase imaging (17).
Although adrenal adenomas and cysts may have similar
attenuation values on CT, they are readily distinguished
on MRI, because cysts are very hyperintense on T2-
weighted images and do not enhance.
A normal CT or MRI appearance does not
exclude hyperplasia. In fact, in the absence of a focal
mass, a patient with biochemical evidence of hypercor-
tisolism and normal adrenals can confidently be given
the diagnosis of hyperplasia as long as exogenous
steroid use is excluded. Most often, both adrenals
become smoothly thickened due to excess ACTH.
The thickening may become massive, especially with
ectopic ACTH production (10).
Adrenal nodules ranging from 6mm to 7cm
may be seen in 12% to 15% of patients with ACTH-
dependent Cushing’s syndrome (10). Although usual-
ly bilateral, such nodules may be unilateral. Careful
examination will usually show some evidence of bila-
teral enlargement. Primary pigmented nodular
adrenocortical disease is a rare disorder that causes
Cushing’s syndrome. It tends to present in younger
patients than the other types of Cushing’s syndrome.
Elevated cortisol is found, with very low ACTH levels.
On CT, multiple bilateral nodules up to 3cm are typi-
cal. Unlike macronodular hyperplasia due to excess
ACTH, the cortex between the nodules is atrophic.
On MRI, the nodules are relatively low signal on both
T1- and T2-weighted images.
PRIMARY ALDOSTERONISM
Primary aldosteronism (Conn’s syndrome) results
from excess adrenal production of the mineralocorti-
coid aldosterone. It is characterized by reduced plasma
renin levels, hypokalemia, and hypertension, with as
Figure 3. Nodular hyperplasia – Diffuse nodular thickening of the adrenal glands (arrows).
Imaging Procedures in Adrenal Pathology
Goldman et al.
597Arq Bras Endocrinol Metab vol 48 nº 5 Outubro 2004
many as 95% of cases resulting from an autonomous
cortical adenoma (aldosteronoma). Most of the
remaining cases result from primary idiopathic bilater-
al hyperplasia. A few rare cases have been reported as a
result of bilateral adenomas, unilateral hyperplasia, and
adrenal carcinoma. Correct diagnosis is important,
because surgical removal of an aldosteronoma is cura-
tive, but partial and even bilateral total adrenalectomy
commonly fails to cure hypertension in patients with
hyperplasia. Adrenal CT should be performed first to
evaluate a patient with biochemical evidence of prima-
ry hyperaldosteronism. Certain biochemical features
are strongly indicative of an aldosteronoma, and CT
should be done to locate the tumor before surgical
removal. If the imaging study is inconclusive, adrenal
venous sampling should be done and all diagnostic
studies correlated prior to surgery.
On CT, aldosteronomas appear as round or
oval lesions, similar to other adenomas, but typical-
ly smaller than cortisol-producing adenomas. They
are rarely larger than 3cm, with a median size of 16
to 17mm. Because of relatively high lipid content,
they often (50%) have an attenuation value similar
to that of water (-10 to +10). This propensity for
low attenuation should be recognized, so that a
low-attenuation mass discovered in a patient with
documented hyperaldosteronism is not misdiag-
nosed as a cyst.
Figure 4. Calcification on a right adrenal adenoma
(arrow).
Figure 5. Cushing’s syndrome due to a cortical adenoma.
The left adrenal (arrowhead) is atrophic in this patient with
hypercortisolism. There is a 3cm right adrenal mass (arrow).
Figure 6. Cushing’s syndrome due to a cortical adenoma. A: T1-weighted GRE image done during suspended respiration
shows a homogeneous 3.0cm mass in the right adrenal (arrow) with signal intensity slightly less than that of liver. B: On the
opposed phase image the mass lost signal.
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Because aldosteronomas are typically small,
they present a greater challenge than cortisol-pro-
ducing adenomas. Early publications reported a
sensitivity of 70% with several false negative CTs
because of inability to detect small aldosteronomas.
With better quality, thin-section CT, a sensitivity
of 80% to 90% has been achieved. With the 5mm-
section technique, false negatives are uncommon
(12% to 14%). Primary adrenal hyperplasia causing
aldosteronism may be micronodular or macron-
odular. The adrenals may appear normal or diffuse-
ly thickened on CT. One or more discrete nodules
ranging from 7 to 16mm may be seen. Diagnostic
errors may occur because of a unilateral nodule that
simulates an adenoma on CT. Conversely, tiny
bilateral nodules that are present in 25% of patients
with aldosteronomas may result in an erroneous
diagnosis of hyperplasia. An accuracy of 80% for
CT showing lack of lateralization (either both
glands are normal, both are enlarged, or there are
bilateral nodules) has been reported. Because of
these potential difficulties, adrenal venous sam-
pling still can be useful in certain patients.
Although aldosteronomas can be shown with MRI,
there is no advantage of MRI over CT. Because
many aldosteronomas are small, the lesser spatial
resolution of MRI is a theoretical disadvantage.
Aldosteronomas are not distinguishable from other
adenomas by any MRI feature. In fact, as with CT,
no MRI feature has been described that indicates
whether an adenoma is hyperfunctioning or non-
h y p e r f u n c t i o n i n g .
ADRENAL CARCINOMA
Adrenal carcinoma is a highly malignant neoplasm that
arises in the adrenal cortex. It is rare, with an incidence
estimated at two cases per million people. It can occur
at any age, with a median age of about 40 years. About
50% of adrenal carcinomas will produce an endocrine
disorder. Cushing’s syndrome is commonest, seen in
about 50% of adrenal carcinoma patients, and it
accounts for 65% of the functional disorders. It may be
seen alone or in combination with virilization. Viril-
ization alone, feminization, and aldosteronism may be
seen, in order of decreasing frequency.
Adrenal carcinomas are often very large when first
detected. This is especially true of nonfunctioning
tumors, which remain clinically silent until advanced
stages, they may be discovered because of flank pain,
fatigue, palpable mass, or evidence of metastases. Even
functioning tumors are usually large at presentation,
which may be a result of relatively inefficient hormone
production. Average size at presentation is 12cm (range,
3 to 30cm). Nowadays, however, with widespread use of
imaging, some of these neoplasms are discovered inci-
dentally and are smaller than previously reported. Ade-
nomas are typically small, round or ovoid, homoge-
neous, with less than 10 Hounsfield units attenuation on
precontrast CT and signal loss on opposed phase images
on MRI and show very slow growth. Adrenal carcinoma
typically shows rapid growth (figure 7). As a result, if
there is concern, a single 6-month follow-up CT can
readily distinguish these entities; lack of growth effec-
tively excludes adrenal carcinoma.
Figure 7. Carcinoma of the Right Adrenal. A: Initial examination shows small nodule of the right adrenal gland (arrow), erro-
neously diagnosed as an adenoma. B: Repeat CT 9 months later shows rapid growth of the mass (arrow), a characteristic
of adrenal carcinoma.
Imaging Procedures in Adrenal Pathology
Goldman et al.
599Arq Bras Endocrinol Metab vol 48 nº 5 Outubro 2004
The histology of adrenocortical carcinoma is
variable. It can be difficult to distinguish a well-differ-
entiated carcinoma from an adenoma, even with a
resected specimen. Needle biopsy may be nondiagnos-
tic. Correlation of histology with radiological features,
and sometimes with biologic behavior, is needed for
diagnosis. The overall prognosis is very poor, with 5-
year survival of 20% to 25%. However, prognosis is bet-
ter (42% to 57%) for localized (stage I) adrenal carcino-
mas if complete surgical resection can be accomplished.
CT readily detects adrenal carcinomas. Most
often they are seen as large, irregularly shaped, hetero-
geneous masses in the adrenal region. Bilateral disease
is seen in less than 10% of cases. Necrosis is common.
Calcification is found in about 40% (12) (figure 8).
Heterogeneous enhancement after intravenous con-
trast is typical, with strong peripheral and little central
enhancement. The tumors may be poorly marginated,
or they may show local invasion. Invasion of the infe-
rior vena cava, liver metastases, and retroperitoneal
lymphadenopathy may be seen. In general, these fea-
tures allow differentiation from adenoma or hyperpla-
sia. However, an incidentally found carcinoma may be
more difficult to discriminate from an adenoma on
CT, as both may be less than 5cm, well circumscribed,
and homogeneous.
On MRI, adrenal carcinomas are easily seen as
large heterogeneous masses in the adrenal bed, with
areas isointense or hypointense to liver on T1-weight-
ed images, and isointense or hyperintense to fat on
T2-weighted images (2) (figure 9). Areas of hemor-
rhage may result in variable signal intensity depending
on the age of the hemorrhage. With multiplanar capa-
bility and the high tissue contrast of T2-weighted
images, MRI can be useful to define the adrenal origin
and the extent of disease (figure 9). After injection of
gadolinium, bright heterogeneous enhancement is
seen (18). The high sensitivity of MRI for venous
involvement and liver disease make it helpful for stag-
ing; venous extension is a poor prognostic sign, and if
metastases are present surgery is not indicated.
PHEOCHROMOCYTOMA
A pheochromocytoma is a neoplasm of the adrenal
medulla that contains chromaffin cells and causes
excess catecholamine production. When such a tumor
arises outside the adrenal, it is labeled a paragan-
glioma. Most are benign, although about 10% are
malignant. Sporadic cases are usually unilateral, affect-
ing the right adrenal slightly more frequently; about
5% are bilateral (figure 10). Most patients are hyper-
tensive. However, pheochromocytoma is found in less
than 1% of the hypertensive population, and in 0.3% of
autopsies. There is an increased likelihood of pheo-
chromocytoma in patients with neurofibromatosis,
von Hippel-Lindau disease, and multiple endocrine
neoplasia (MEN) syndromes (50% in MEN 2 and 90%
in MEN 2b). In such syndromes and in children, mul-
tiple or bilateral cases are more likely. In MEN 2b,
bilateral tumors are so common that bilateral adrena-
lectomy is recommended, because lesions may recur
after unilateral surgery.
In most cases, diagnosis of pheochromocytoma
can be established with biochemical testing. However,
Figure 8. Adrenal carcinoma. A: Precontrast CT shows a heterogeneous 8cm left adrenal mass (*) containing a small
amount of calcification (arrow). B: The mass shows moderate, heterogeneous enhancement after contrast.
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biochemical tests are expensive, time consuming and
fraught with difficulty, because such factors as episodic
catecholamine production, concurrent medication,
stress, inadequate urine collection for 24-hour samples,
and other factors can contribute to both false positive
and false negative results. Detection and localization are
important because surgical resection is curative, and
because there is no effective medical therapy.
Although 90% of pheochromocytomas arise in
the adrenal, up to 10% are extra-adrenal (figure 11),
with many such lesions (7%) in the infrarenal portion
of the retroperitoneum, arising in the organ of Zuck-
erkandl (figure 11). Paragangliomas can be single or
multiple, and they may have greater malignant poten-
tial. Paragangliomas also can be found in the neck, the
mediastinum, and the wall of the urinary bladder.
Pheochromocytomas are usually over 3cm at
presentation and should be invariably identified by
CT. When small, the tumors are round and have
homogeneous soft-tissue attenuation values (figure
12). Because pheochromocytomas are hypervascular
neoplasms, they have a propensity to undergo hemor-
rhagic necrosis even when benign, accounting for the
central low attenuation seen in large neoplasms. Cen-
Figure 9. Cushing’s syndrome due to adrenal carcinoma. A: Post-contrast CT shows a heterogeneous right adrenal mass
(arrow) with non-enhancing area. B: T1-weighted GRE sequence. C: On T2-weighted sequence (with fat suppression) most
of the mass is moderately hyperintense, with a very hyperintense area (arrow) corresponding to the non-enhancing area
on CT, representing an area of necrosis. D: Coronal image following intravenous administration of Gd-DTPA, there is het-
erogeneous enhancement (arrow).
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tral necrosis may be so extensive as to simulate a cyst.
Calcification is uncommon; when present, it may have
an eggshell pattern. After intravenous administration
of iodinated contrast medium, pheochromocytomas
exhibit heterogeneous enhancement, a pattern indis-
tinguishable from a malignant adrenal neoplasm. Cor-
relation with biochemical function is required to
establish the correct diagnosis.
Because pheochromocytomas are large, they
can be detected even with unenhanced CT. Some con-
cern has been raised about the use of intravenous con-
trast in patients with pheochromocytoma. Plasma cat-
echolamine levels can be raised by intravenous injec-
tion of iodinated contrast medium, but symptomatic
blood pressure elevations do not usually result. Only if
a patient has had hypertensive episodes and no ade-
quate pharmacologic adrenergic blockade is it neces-
sary to avoid contrast. Contrast is especially useful for
detection of extra-adrenal lesions. Although paragan-
gliomas can usually be identified on CT (figure 11),
they have a nonspecific appearance. The CT features of
malignant paragangliomas in particular overlap with
those of other retroperitoneal malignancies. Radionu-
clide metaiodobenzylguanidine (MIBG) scintigraphy
can be useful to document whether a retroperitoneal
mass is in fact a paraganglioma.
Pheochromocytomas have a rather characteris-
tic appearance on MRI (2,3). They are readily detect-
ed (with a sensitivity of 100% in one report), because
they are several centimeters in diameter. When small,
they are usually homogeneous and isointense to mus-
cle, hypointense to liver on T1-weighted images, and
have a distinctive marked signal hyperintensity relative
to fat on T2-weighted images (3) (figures 12 and 13).
As they grow and develop central necrosis, there may
be central areas that are hyperintense on both T1- and
T2-weighted images.
Persistent enhancement after intravenous
gadolinium is typical (18). Because no lipid is found in
pheochromocytoma, there is no decrease in signal on
opposed phase images. Paragangliomas have similar
distinctive imaging characteristics; as a result, MRI is
superior to CT for diagnosis of paragangliomas, and
nearly as sensitive as MIBG. Because most such
tumors lie in the adrenal or retroperitoneum, coronal
MRI can quickly and effectively show the area of
abnormality.
Biopsy of a mass suspected to be a pheochro-
mocytoma is not recommended, especially if adequate
hypertensive control has not been achieved, as several
episodes of severe hemorrhage and even death have
resulted following percutaneous biopsy. MIBG has
both high sensitivity and high specificity, and it can
detect a paraganglioma in any part of the body. How-
ever, it is an expensive test that requires up to 72 hours
to complete and is not widely available. Furthermore,
it does not provide sufficient anatomic detail for surgi-
cal planning. It is most useful in evaluating patients
Figure 10. Multiple pheochromocytomas in MEN2b. A and B: CT shows bilateral heterogeneous adrenal tumors (arrows).
Figure 11. Organ of Zuckerkandl paraganglioma.
Enhanced CT shows a mass at the aortic bifurcation (arrow).
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with a strong clinical suspicion and in whom CT or
MRI is normal or equivocal, or for follow-up of malig-
nant lesions.
The follow up for these patients should be very
judicious and information on clinical presentations and
surgical data should be included and taken into
account during analysis of exam results, be they from
a CT or from an MR. The presence of hypertension in
this group of patients is not always indicative of persis-
tence or recurrence of the disease. Other causes of
hypertension should be evaluated, such as renal
changes due to chronic disease.
NONHYPERFUNCTIONING NEOPLASMS
Nonhyperfunctioning adrenal neoplasms are clini-
cally silent until they become very large, although
they may present with pain if they bleed. Current-
ly, most such masses are found incidentally on
studies performed for other reasons. About 30% of
all adrenal masses are incidentally detected by CT.
An adrenal mass is seen in about 4% of all abdomi-
nal CT scans, with one third being serendipitous
findings; the remainder are either metastases in
patients with known malignancies, or they are
functioning lesions. Most incidental adrenal masses
are benign and of no clinical significance, especial-
ly in patients with no known malignancy. In two
large series, only 6.7% and 9% of serendipitous
adrenal masses were subsequently proven malig-
nant. Although historically size has been consi-
dered an important factor, larger tumors having a
greater likelihood of malignancy, size is an imper-
fect criterion. Although malignant neoplasms were
all larger than 6.5cm in one study, and most
benign masses are less than 5cm, there is conside-
rable overlap. The majority of incidental masses
greater than 5cm are still benign in patients with
no history of malignancy, and lesions as small as
1cm may be metastases (13). Thus, imaging crite-
ria are required for differentiation.
Figure 12. Pheochromocytoma in a man with episodic hypertensive crises. A: Homogeneous right adrenal mass on CT
image (arrow). B: On T1-weighted image (366/26), the mass (arrow) has signal intensity similar to liver. C: On T2-weighted
image (2500/80), the mass (arrow) is homogeneous and more intense than fat.
Figure 13. Pheochromocytoma. A: Post-contrast CT shows a right adrenal mass (arrow) with marked heterogeneous
enhancement. B: On fat-suppressed T2-weighted image (2500/70), the mass (arrow) is markedly hyperintense.
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NONHYPERFUNCTIONING ADENOMAS
Nonhyperfunctioning adrenal adenomas are not infre-
quent, being found in 2% to 8% of autopsies (1,65)
and in 1% to 2% of abdominal CT scans. They are
most commonly unilateral, although bilateral adeno-
mas do occur. Although nonhyperfunctioning adeno-
mas may be 6cm or larger (13), the majority is 3cm or
less, with only 5% exceeding 5cm. Calcification may
be present (12).
Nonhyperfunctioning adenomas have a CT
appearance indistinguishable from other adenomas,
except that contralateral atrophy is not present. They
are smooth, round or oval, with a well-defined margin.
CT densitometry can be used to accurately dif-
ferentiate benign from malignant adrenal masses. Lee
et al. reported the use of nonenhanced CT attenua-
tion values for the characterization of adrenal masses
where most adenomas had attenuation values lower
than those of malignant masses (15). Korobkin et al.
and Boland et al., confirmed these findings. Boland
pooled the data from 10 articles and showed that a
sensitivity of 71% and a specificity of 98% result from
choosing a threshold value of 10HU for the diagno-
sis of adrenal adenoma. Ninety-eight percent of
homogeneous adrenal masses with a nonenhanced
CT attenuation value of 10HU or less will be benign
(most will be adenomas), whereas 29% of adenomas
will have an attenuation value of more than 10HU
and will be indistinguishable from most nonadeno-
mas, including metastases.
Chemical shift MR imaging can be used to dif-
ferentiate adrenal nodules. A relative loss in signal
intensity in an adrenal mass, when opposed-phase
and in-phase images are compared, can be used to
characterize many adrenal masses as benign adeno-
mas (figure 14). Adrenal adenomas, unlike most me-
tastases and other nonadenomas, often contain large
amounts of intracellular lipid (17). The sensitivity
and specificity for the diagnosis of adrenal adenoma
are similar for chemical shift MR imaging and nonen-
hanced CT densitometry. A histologic study of re-
sected adenomas that had undergone presurgical CT
and/or MR imaging showed a linear correlation
between the percentage of lipid-rich cortical cells and
both the nonenhanced CT attenuation value and the
relative change in signal intensity on opposed-phase
chemical shift MR images.
A substantial minority of adrenal adenomas is
lipid-poor and cannot be characterized by means of
their nonenhanced CT attenuation. Korobkin et al.
established washout curve values for adenomas. The
adenomas, notwithstanding the presence and quanti-
ties of lipids in their composition, have the property of
presenting rapid loss of enhancement and attenuation
values at 15 minutes, which can be used to differenti-
ate them from other masses (figure 15).
The established formula for this calculation
includes the density of the lesion during the precon-
trast, portal (60sec) and 15-minute delay phases. The
exam should be performed with thin collimation and
the attenuation measurements must have the region-
of-interest (ROI) spanning 1/2 to 2/3 the area of the
lesion, always in the same position. Calcified and
necrotic nodules are not suitable for this calculation.
Washout values of more than 60% are indicative of
adenomas, whereas those less than 60% indicate inde-
terminate masses (figure 15).
Figure 14. MRI on Left Adrenal Adenoma. A: T1-weighted GRE image done during suspended respiration shows a 2.0cm no-
dule in the right adrenal (arrow) with signal intensity similar to liver. B: On the opposed phase image the nodule lost signal.
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The percentage enhancement washout is calcu-
lated as follows:
% enhancement washout= (E-D/E-U) x 100,
where:
E= Enhancement: attenuation at portal phase
D= delayed enhanced attenuation at 15min
U= attenuation at pre contrast
In summary, the evaluation of a known adrenal
mass starts by using nonenhanced CT. If the attenua-
tion of the mass is 10HU or less the diagnosis is, most
of the times, a lipid-rich adrenal adenoma and a small
fraction of these will be cysts. In such a case, there is
no need for further evaluation. If the attenuation is
more than 10HU, the mass is considered to be inde-
terminate and an enhanced and 15-minute-delayed
enhanced CT scan should be done. If the enhance-
ment washout is more than 60%, the most likely diag-
nosis is of a lipid-poor adenoma. Again, there is no
need for further evaluation. If the enhancement
washout is less than 60%, the mass is considered inde-
terminate. Percutaneous adrenal biopsy is recom-
mended if the patient has a primary neoplasm with no
other evidence of metastases. In a patient without can-
cer, surgery is recommended if the mass measures
more than 4 – 5cm. Follow-up CT, or adrenal scintig-
raphy with the use of radioiodinated norcholesterol
(NP-59) can also be done in this group of patients.
METASTATIC DISEASE
Metastases to the adrenals are common from a variety
of primary malignancies, including thyroid, renal, gas-
tric, colon, pancreatic, and esophageal carcinomas, and
melanoma. Lung and breast cancer, however, are the
most common sources, with adrenal metastases found
on CT in approximately 19% of lung cancer patients.
Because adrenal metastases are so common in lung
cancer and the adrenals may be the only site of metas-
tasis, they should be included in the CT examination
of all patients presenting with lung cancer. Even in
patients with lung cancer, about one third of adrenal
masses are benign. Thus, imaging features must be
used to help make the correct diagnosis. If the imaging
findings are equivocal, a percutaneous CT-guided
biopsy should be performed to establish a histologic
diagnosis. A baseline CT at the time of presentation of
patients with lung cancer is a useful aid in follow-up.
Detection of a new small adrenal mass on follow-up is
clear evidence of metastasis if the baseline showed nor-
mal adrenals.
Adrenal metastases can vary considerably on
CT. Size can range from less than a centimeter to large
masses; the size, however, overlaps with that of ade-
nomas (13) (figure 16). Adrenal metastases may be
unilateral or bilateral. When small (< 5cm), they com-
monly are fairly well circumscribed, round or oval, and
of soft-tissue density. They may have smooth or irreg-
ular, lobulated contours. They may show local inva-
sion, a sign of malignancy. Calcification is rare (12),
and they may bleed (14).
Small adrenal metastases are solid tumors and
thus usually have homogeneous soft-tissue-attenua-
tion values, similar to or higher than that of muscle on
noncontrast scans. Even if there is central necrosis,
however, the density is not lower than that of water,
because malignant tumors do not produce lipid (15).
Following intravenous administration of iodi-
nated contrast material, there may be homogeneous
enhancement, but commonly enhancement is hetero-
geneous, especially with larger tumors. A thick, nodu-
lar enhancing rim also may be seen (16).
Adrenal metastases can vary in size and appear-
ance on MRI. On T1-weighted images, metastases
usually have signal intensity similar to or lower than
that of normal liver tissue, not distinctly different from
Figure 15. Right Adrenal Adenoma. CT images on precontrast phase (A), portal post-contrast phase (B) and 15-minute-
delayed post-contrast phase (C). Washout values of more than 60% are indicative of adenoma (E-D/E-U x 100 =
115,3–54,6/115,3-18,0 x 100 = 64%).
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that of adenomas. They may be heterogeneous (2,3).
On T2-weighted images, they are often heteroge-
neous, and they are usually hyperintense compared to
normal liver, often similar to or of higher intensity
than fat, unlike the typical adenoma (2,3). Numerous
calculations based on signal intensity ratios, or calcu-
lated T2 values, have been investigated, but none have
been found to be reliable in practice for distinguishing
metastases from adenomas (2,5). Because metastases
do not produce lipid, there is no decrease in signal on
opposed phase images (17). This has been shown to
be a more consistent finding than T2 values. After
intravenous administration of gadolinium compounds,
metastases exhibit exuberant and heterogeneous
enhancement that persists for several minutes, an
enhancement pattern quite different from that of ade-
nomas (18). MRI is readily able to demonstrate or
exclude local invasion because of the great contrast
between neoplastic and normal tissue, especially on
fat-suppressed T2-weighted images.
Computed tomography is the most cost-effec-
tive method for screening and following patients with
malignancies. In most cases, adrenal metastases can be
diagnosed or excluded by a well-performed CT. MRI
can be valuable in cases in which CT could not be per-
formed. Percutaneous biopsy under CT guidance can
be very effective, with accuracy and negative predictive
value of over 90% (19). However, complications can
occur, and biopsy is not needed if the imaging findings
are diagnostic. Follow-up by CT can be diagnostic,
because adenomas are very slow growing and will not
change in size over a period of a few months, while
metastases will show growth.
Neoplastic patients frequently show a diffuse
enlargement of the adrenal glands but with no masses
or changes in contours. Biochemical studies carried
out with this group of patients have demonstrated a
number of changes in the gland function, which are
shown to be consistent with hyperplasia. A definite
association between malignant neoplasms and adrenal
gland hyperplasia is observed; there is a higher preva-
lence of adrenal gland hyperplasia in tumors patients
when compared to the general population (20).
ADRENAL LYMPHOMA
Lymphoma occasionally involves the adrenal glands,
with diffuse non-Hodgkin’s being the commonest
type. This may be found at presentation or at follow-
up, with adrenal lymphoma reported in 1% to 4% of
patients being followed up for lymphoma. Adrenal
involvement is most commonly seen in conjunction
with an extra-adrenal disease site. Primary adrenal lym-
phoma is rare and is believed to arise from hematopoi-
etic cells in the adrenal (21).
Lymphomatous adrenal masses are bilateral in
one third of cases; when bilateral, the patient may
develop Addison’s disease.
On CT, adrenal lymphomas usually are seen as
large soft-tissue masses replacing the adrenal. Mild to
moderate enhancement is seen after intravenous
administration of iodinated contrast (figure 17). The
lesions may be homogeneous, but they are often het-
erogeneous with low attenuation areas even before
therapy (21). Sometimes the growth pattern can sug-
Figure 16. Adrenal metastasis. A: Metastatic lung cancer to adrenal glands (arrows). B: Metastasis from Hepatocellular Car-
cinoma to right adrenal (arrow).
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gest lymphoma, as it is more likely to infiltrate or
insinuate around the upper pole of the kidney than
displace it, as would be typical of carcinoma. There
may be hemorrhage, and calcification can be found,
especially after chemotherapy (21). On MRI, adrenal
lymphomas are indistinguishable from other malig-
nancies. They are usually heterogeneous, with low sig-
nal on T1-weighted images (less intense than normal
liver, but more intense than muscle) and more intense
than fat on T2-weighted images (2,22).
MYELOLIPOMA
Myelolipoma is an uncommon, benign, nonfunction-
ing neoplasm of the adrenal, found in less than 1% of
autopsies. It is composed of variable amounts of fat
and hematopoietic tissue, including myeloid and ery-
throid cells and megakaryocytes. It affects men and
women equally. Although this is a nonfunctioning
tumor, in 10% of cases it is associated with endocrine
disorders, including Cushing’s syndrome, congenital
adrenal hyperplasia, and Conn’s syndrome. Most
myelolipomas (80%) are asymptomatic and of no clin-
ical significance. Some (10%) become large and cause
vague symptoms or pain. Large myelolipomas may
hemorrhage, which can be the cause of pain. Size
ranges from 1 to 15cm, with a mean of about 4cm.
On CT, most myelolipomas are well-circum-
scribed masses, sometimes with a discrete thin appar-
ent capsule (figure 18). Occasionally, the mass may
appear to extend into the retroperitoneum. Nearly all
contain some definite fat density (< -20HU). Howe-
ver, the amount of fat is widely variable, ranging from
nearly all fat, to more than half fat (50%), to only a few
tiny foci of fat in a soft-tissue mass (10%) (23). Occa-
sionally, the mass has an attenuation value between
that of fat and water because the fat and myeloid ele-
ments are diffusely mixed. Calcification is seen in 30%,
often punctate. With hemorrhage, high-density areas
can be seen. Bilateral myelolipomas occur in about
10% (23).
The presence of fat in an adrenal mass also can
be recognized on MRI, because fat is typically bright
on both T1- and T2-weighted images (figure 18).
Decrease in signal with fat suppression or phase can-
cellation is confirmatory (17) (figure 18). However, if
the mass is nearly all mature fat, there will not be loss
of signal with opposed phase images, because the loss
of signal occurs only with phase cancellation in areas
with an admixture of fat and water protons (24).
Overall, myelolipomas are often heterogeneous
because the nonfatty areas will have signal intensity
similar to that of hematopoietic bone marrow. The
lesions enhance brightly after intravenous administra-
tion of gadolinium.
The presence of fat in an adrenal mass is the key
to the diagnosis of myelolipoma, because virtually no
other adrenal lesion contains fat. Teratoma and
liposarcoma of the adrenals are extraordinarily rare. An
angiomyolipoma of the upper pole of a kidney may be
mistaken to be an adrenal myelolipoma. However, this
is of no clinical significance, because both these lesions
are benign. If necessary, diagnosis can be confirmed by
percutaneous needle biopsy. If the biopsy reveals bone
marrow elements and the mass contains fat, the diag-
Figure 17. Adrenal lymphoma. A: Bilateral lobular adrenal masses (40HU) are present on noncontrast CT in this patient pre-
senting with adrenal insufficiency (arrows). B: Contrast-enhanced scan shows slightly heterogeneous, mild enhancement
(88HU). The patient was Addisonian.
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nosis is assured, because extramedullary hematopoiesis
does not contain fat. The presence of megakaryocytes
also is an important diagnostic histologic feature. A
definite diagnosis is important because surgical resec-
tion is not indicated unless there has been significant
hemorrhage. In nearly all cases, a diagnosis of adrenal
myelolipoma can be made confidently based on CT or
MRI findings alone.
ADRENAL CYSTS
Adrenal cysts are rare, found in only 1 of 1,400 autop-
sies. They are nonfunctional and usually found inci-
dentally. The commonest (45%) type is endothelial
cyst. These are predominantly lymphangiomatous
cysts, typically small and asymptomatic. Thirty-nine
percent are pseudocysts, which lack an endothelial lin-
ing and are most often a sequelae of remote adrenal
hemorrhage. These are the type most often detected
by CT. These can be quite large and may produce
symptoms because of their size. The remaining cystic
lesions of the adrenals are parasitic cysts (7%), caused
by Echinococcus, and true epithelial cysts (9%).
On CT, adrenal cysts are large masses (5 to
20cm) that are well circumscribed and round. They
are suprarenal in location, but it may be difficult on
CT to recognize that they arise in the adrenal rather
than the kidney or liver. Sonography or MRI may bet-
ter show their true origin. They usually are of near-
water attenuation, but they can have higher or mixed
attenuation values resulting from old hemorrhage.
The wall may be thick and can show contrast enhance-
ment. Calcification is common (75%) (12), being usu-
ally curvilinear in shape and often limited to the infe-
rior aspect of the wall. (12). Although MRI may show
typical cystic features, homogeneous low intensity on
T1-weighted images and extreme hyperintensity on
Figure 18. Patient with adrenal hyperplasia due to bilateral nodules, one at the right side is calcified (arrowhead) and a
large left mass with predominant fat content (-25HU) characteristic of a myelolipoma (arrow) (A). T1 in phase (B), T1 out of
phase (C) and T2 with fat saturation (D) MRI images. Out of phase shows no significant signal decrease compared to in
phase. Fat saturation shows a significant decrease of signal, compatible with extra cellular lipid.
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T2-weighted images, signal intensity can vary depend-
ing on the age of hemorrhage. There is no central
enhancement on either CT or MRI. Adrenal cysts are
of no clinical significance, and surgical removal is
unnecessary if the diagnosis can be established by
imaging. Concern about malignancy is reasonable only
in complicated cysts, which may have high attenuation
values, a thick enhancing wall, and septations. In such
cases, percutaneous needle aspiration may be helpful
for both diagnosis and treatment.
INFLAMMATORY DISEASE
Inflammatory processes in the adrenals are uncom-
mon. Adrenal abscesses occur rarely; they sometimes
represent adrenal hematomas that became infected.
More often, adrenal inflammation is due to chronic
granulomatous disease, with tuberculosis (TB) and
histoplasmosis most common, although North Ame-
rican blastomycosis has been reported to involve the
adrenals. Paracoccidioidomycosis, or South American
blastomycosis, is the most common systemic mycosis
in South America, with Brazil responsible for about
70% of total world cases. Its etiologic agent is Para-
coccidioides brasiliensis. This disease chiefly involves
the respiratory tract and its presentation can vary from
acute and self-limited to a progressive pulmonary dis-
ease or extra pulmonary dissemination. Diagnosis is
made by lesion biopsy and fungal culture, serological
tests and chest radiographs. The organs that constitute
the reticuloendothelial system, including the adrenals,
are the most affected ones.
Granulomatous disease of the adrenals can
cause a variety of appearances depending on the dis-
ease stage. In most cases, there is bilateral enlargement
of the adrenals (25). Bilateral adrenal enlargement in a
patient with a reactive tuberculin skin test, or with
chest radiographic changes of TB, paracoccidioidomy-
cosis or histoplasmosis, should suggest the diagnosis,
even if pulmonary cultures are nondiagnostic.
With active adrenal TB or paracoccidioidomyco-
sis, both glands are usually enlarged to some degree for
a disease course of less than 3 months (acute stage) (fi-
gure 19). The masses have frequently heterogeneous
enhancement and low-attenuation central areas repre-
senting caseous necrosis (26). Enlarged glands and
inward atrophic areas are found in the subacute stage of
the disease (disease course of 6 to 24 months) (27).
Calcification is present in nearly half of cases of
adrenal TB or paracoccidioidomycosis (35,161). Atro-
phy is seen at the chronic stage, when the disease
exceeds 24 months. In some cases, at a late disease
stage, dense calcification with no soft-tissue mass may
be seen (28). Active adrenal histoplasmosis most often
presents with mild to marked symmetrical enlarge-
ment of both adrenals, which retain the normal shape
(30). There is low attenuation in the center with high-
er peripheral density, because of caseous necrosis (30).
Calcification is not usually seen in the acute phase, but
it may be seen with healing.
With TB, paracoccidioidomycosis and histo-
plasmosis, there may be associated lymphadenopathy.
All may cause adrenal insufficiency. The diagnosis usu-
ally is suggested because of the CT appearance of the
glands and the clinical presentation, especially when
there is adrenal insufficiency. Percutaneous biopsy can
be done to confirm the diagnosis (28).
The MRI signal intensity of inflammatory
adrenal masses is nonspecific. It has signal intensity
similar to spleen on T1-weighted images, and similar
to or higher than fat on T2-weighted images.
Enhancement patterns have not been described. Calci-
fication is difficult to recognize.
Figure 19. Adrenal Paracoccidioidomycosis. A: Acute stage – Bilateral adrenal enlargement with areas of necrosis (arrows).
B: Subacute stage – Bilateral adrenal atrophy with segmental enlargement (arrows). C: Chronic stage – Bilateral adrenal
atrophy (arrows).
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ADRENAL HEMORRHAGE
Adrenal hemorrhage occurs in three distinct settings:
neonatal hemorrhage, spontaneous (atraumatic) he-
morrhage in the adult and severe trauma. Neonatal
hemorrhage is the most common, resulting partly
from the large fetal adrenal that is prone to injury du-
ring birth trauma. Because it is primarily the regressing
fetal adrenal tissue that is involved, such patients do
not develop adrenal insufficiency, and in the adult the
only sequelae is calcification of the adrenal without an
associated mass (12).
Adrenal hemorrhage in the adult may be seen in
the setting of severe illness, such as sepsis, including but
not limited to meningococcemia, burns, hypotension,
and other life threatening illnesses. In these circum-
stances, it is likely that the stress-related hyperplasia
makes the adrenal prone to spontaneous rupture.
About one third of cases of adrenal hemorrhage are
associated with anticoagulant therapy. Commonly, the
bleeding occurs in the first 3 weeks of anticoagulation.
On CT, adrenal hemorrhage results in unilateral or
bilateral adrenal masses that are usually ovoid, about
3cm in diameter, and of about muscle density or high-
er with poor enhancement, if any, after intravenous
administration of iodinated contrast. With larger hem-
orrhages, the masses may be heterogeneous and may
have ill-defined margins. The size and attenuation value
decrease over time if followed with CT. Calcification
may develop in several weeks to months. If the hemor-
rhage is bilateral, adrenal insufficiency may occur.
The adrenal glands are well protected in the
retroperitoneum. Posttraumatic adrenal hemorrhage is
uncommon, reported in 2% of patients having CT for
severe abdominal injury (31). The lack of specific clin-
ical signs makes acute traumatic adrenal hemorrhage a
usually incidental finding in CT studies performed for
evaluation of acute blunt trauma. It has long been rec-
ognized that the right adrenal is more prone to trau-
matic hemorrhage (31). However bilateral and isolat-
ed left adrenal hematomas occur.
Metastases to the adrenal can bleed, but only
rarely. This usually can be distinguished from other
adrenal hemorrhages because there is a large hetero-
geneous mass, with more extensive infiltrative
retroperitoneal bleeding (14). Because these patients
usually have advanced disease, neoplasm elsewhere is
also usually evident.
On MRI, adrenal hemorrhage will produce a
mass that can have varying signal intensities dependent
on the age of the blood. They usually have a pattern
distinct from that of an adenoma or malignancy. A
subacute hematoma usually has high signal intensity
on both T1- and T2-weighted images (figure 20). In
some cases of subacute hematoma, on T1-weighted
images the center may be low intensity because of the
presence of intracellular deoxyhemoglobin, and the
periphery may have high signal because of free methe-
moglobin; because both substances are high signal on
T2, the mass is all high signal on T2. In chronic adren-
al hematoma, the center consists of methemoglobin
and thus this is of high signal on T1- and T2-weight-
ed images, whereas the periphery contains hemo-
siderin, which is low signal on both T1- and T2-
weighted images. This ring pattern is quite distinctive
and suggestive of the diagnosis (33).
Figure 20. Traumatic adrenal hematoma. A: Unenhanced CT in a patient who was in a motor vehicle accident shows ovoid
hyperdense right adrenal mass (arrow). B: T1-weighted GRE image shows the mass with very hyperintense signal (arrow).
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ADDISON’S DISEASE
Adrenal insufficiency may result from a variety of caus-
es including bilateral hemorrhage, inflammatory dis-
ease, and idiopathic autoimmune primary Addison’s
disease. Although metastases to the adrenal are com-
mon, they rarely lead to Addison’s disease. When it
occurs, the disease is either in advanced stages or is
associated with spontaneous hemorrhage. Another
rare cause is hemochromatosis, which can be recog-
nized on CT, as the adrenals are normal or small in
size but have increased attenuation values (28).
CT is indicated in evaluation of patients with
Addison’s disease. In one study, all cases of idiopathic
Addison’s disease could be distinguished from other
etiologies (29).
CT can also determine the stage of the dis-
ease: acute, subacute and chronic, as discussed pre-
viously (27).
Adrenal atrophy that results from autoimmune
disease will result in small glands without calcification
(28,29). This must be distinguished from adrenal atro-
phy due to exogenous steroids, which has a similar
appearance, by careful history taking. Conversely,
either adrenal hemorrhage, neoplasms, or inflammato-
ry disease will show either adrenal masses or calcifica-
tion, as discussed previously. Small adrenals that are
partly or completely calcified suggest old granuloma-
tous disease (particularly TB and Pb), whereas very
dense calcifications with no soft tissue component sug-
gest remote adrenal hemorrhage.
CT AND OTHER IMAGING METHODS
Except in a pediatric population, ultrasound is not
used as a primary imaging method for adrenal disease,
because it has both lower sensitivity and specificity
than CT or MRI. Adrenal angiography and venogra-
phy have been replaced by CT and MRI. Adrenal
venous sampling remains useful in certain cases.
Adrenal scintigraphy is useful in patients sus-
pected of having primary extra-adrenal or malignant
metastatic pheochromocytomas.
MRI is extremely useful in selected cases, par-
ticularly in the evaluation of pheochromocytomas and
paragangliomas. MRI is equivalent to CT in evaluation
of Cushing’s syndrome. However, CT is preferred for
evaluation of hyperaldosteronism or adrenal insuffi-
ciency. MRI can be very useful to further characterize
lesions detected on CT. It can demonstrate more
clearly the extent of a mass, its exact organ of origin,
and vascular compromise. MRI can be useful in evalu-
ating an adrenalectomy bed for possible recurrence of
a malignancy, because spin echo images show less
degradation by clip artifact than CT. Last, pregnant
patients suspected of having adrenal disease can be
more safely studied with MRI than with CT.
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